TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study

Journal:

Nature Communications

Published:

2025-05-28

DOI:

10.1038/s41467-025-60281-8

Affiliations:

6

Authors:

18

Go to article

Institutions	Authors	Share
Leiden University Medical Center (LUMC), Netherlands	11.000000 11.000000	0.61
Erasmus University Medical Center (Erasmus MC), Netherlands	5.000000	0.28
University Medical Center Groningen (UMCG), RUG, Netherlands	2.000000	0.11

Interested in Oncology and Carcinogenesis?